Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
11,863
Value
$2.00M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of NBIX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,863$2.00M<0.1%−46,105−79.5%ReducedHolders
Q1 202657,968$7.64M<0.1%−21,743−27.3%ReducedHolders
Q4 202579,711$11.3M<0.1%−713,528−90.0%ReducedHolders
Q3 2025793,239$111.4M0.1%−1,255,836−61.3%ReducedHolders
Q2 20252,049,075$257.5M0.2%+1,160,047+130.5%AddedHolders
Q1 2025889,028$98.3M0.1%−1,649,081−65.0%ReducedHolders
Q4 20242,538,109$346.5M0.3%+773,519+43.8%AddedHolders
Q3 20241,764,590$203.3M0.2%+1,023,651+138.2%AddedHolders
Q2 2024740,939$102.0M0.1%−100,379−11.9%ReducedHolders
Q1 2024841,318$116.0M0.1%+729,318+651.2%AddedHolders
Q4 2023112,000$14.8M<0.1%−624,207−84.8%ReducedHolders
Q3 2023736,207$82.8M0.1%−570,066−43.6%ReducedHolders
Q2 20231,306,273$123.2M0.1%+831,881+175.4%AddedHolders
Q1 2023474,392$48.0M0.1%+288,824+155.6%AddedHolders
Q4 2022185,568$22.2M<0.1%−50,078−21.3%ReducedHolders
Q3 2022235,646$25.0M<0.1%+235,646NewHolders
Q2 20220$00.0%−93,098−100.0%Sold outHolders
Q1 202293,098$8.73M<0.1%−729,731−88.7%ReducedHolders
Q4 2021822,829$70.1M0.1%−21,172−2.5%ReducedHolders
Q3 2021844,001$80.9M0.1%+176,015+26.4%AddedHolders
Q2 2021667,986$65.0M0.1%−467,361−41.2%ReducedHolders
Q1 20211,135,347$110.4M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.